300+ investors in your industry, stage, and region Get
Any industry
Hospitality
Video Games
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Energy
SaaS
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Retail
Oil and Gas
Payments
Film
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Social Network
B2B
Wellness
Education
Medical Device
Automotive
eSports
Sports
Legal
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Medical
Infrastructure
Venture Capital
Web3
Beauty
Fashion
Social
Theatre
Celebrity
LGBT
Climate
Cannabis
Wine and Spirits
Mobile Apps
Life Science
Food and Beverage
Publishing
Art
Music
Real Estate
Recruiting
Sporting Goods
FinTech
Finance
Digital Media
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Sustainability
Proptech
Hardware
Impact
Crowdfunding
Transportation
Biotech
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
Japan
South Korea
Singapore
Gibraltar
Egypt
Oceania
Taiwan
Zimbabwe
Tunisia
Sweden
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Kyrgyzstan
Haiti
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Burkina Faso
LATAM
Brazil
Africa
Oman
Puerto Rico
Poland
Colombia
Guernsey
Cameroon
Armenia
China
Costa Rica
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Jamaica
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Uganda
Myanmar
Turkey
Uruguay
Moldova
Botswana
Seychelles
Paraguay
South Africa
France
Denmark
Georgia
Ghana
Iraq
Portugal
Philippines
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Angola
Europe
Cyprus
Argentina
Spain
Qatar
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Faroe Islands
Estonia
Bahrain
Bahamas
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Lithuania
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Bangladesh
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Biotech Startup Investors in Austria (October 2026)

The most active venture capital funds and angel investors investing in Austria Biotech startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Austria Biotech startup companies. Find investors to raise a Pre-Seed, Seed or Series A round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
XISTA Science Ventures
VC Fund
19 Austria, Germany, France Seed, Pre-Seed, Series A Biotechnology, Medical, Software $552k–$20M
SOSV
VC Fund
13 United States, China, Canada Seed, Convertible Note, Pre-Seed Biotechnology, Health Care, Software $50k–$5M
tecnet equity
VC Fund
9 Austria Seed, Series A, Venture - Series Unknown Software, Biotechnology, Artificial Intelligence $208k–$20M
xista science ventures
VC Fund
9 Austria, Slovenia Seed, Pre-Seed, Series A Biotechnology, Medical, Software $552k–$20M
austria Wirtschaftsservice (aws)
VC Fund
6 Austria, Belgium Seed, Grant, Pre-Seed Software, Information Technology, Artificial Intelligence $61k–$2.7M
aws Gründungsfonds
VC Fund
4 Austria, Germany, United States Seed, Series A, Venture - Series Unknown Software, SaaS, Information Technology $1.1M–$11M
MIG Capital
VC Fund
4 Germany, France, Austria Series A, Series B, Venture - Series Unknown Biotechnology, Health Care, Software $1.7M–$60M
Arax Capital Partners
VC Fund
4 Austria, United States Venture - Series Unknown, Seed, Series A Biotechnology, Software, Health Care $271k–$10M
PUSH VC
VC Fund
3 Austria, Germany, United States Seed, Pre-Seed, Series A Software, Apps, Health Care $650k–$31M
FPS-Holding
VC Fund
3 Austria Seed Biotechnology, Health Diagnostics $420k–$1.5M
Lansdowne Partners
VC Fund
3 United Kingdom, Austria, United States Series A, Series B, Series C Biotechnology, Information Technology, Finance $6.7M–$162M
10x Founders
VC Fund
3 Germany, United States, Switzerland Seed, Series A, Pre-Seed Software, Artificial Intelligence, Information Technology $620k–$53M
REVENTON
VC Fund
2 Austria Venture - Series Unknown Software, InsurTech, Insurance $1.2M–$1.8M
The Austrian Research Promotion Agency (FFG)
VC Fund
2 Austria, United States, Belgium Grant, Seed, Pre-Seed Software, Artificial Intelligence, Medical $67k–$3.5M
SkyGene
VC Fund
2 Austria Venture - Series Unknown Medical, Health Care, Biotechnology
BackBone Ventures
VC Fund
2 Switzerland, Germany, Israel Pre-Seed, Seed, Series A Artificial Intelligence, Software, Information Technology $578k–$105M
KHAN Technology Transfer Fund
VC Fund
2 Germany, Austria, Belgium Seed, Pre-Seed, Series A Biotechnology, Medical, Biopharma $259k–$10M
GreyBird Ventures
VC Fund
2 United States, Germany, China Series A, Seed Health Care, Medical, Biotechnology $3M–$16M
Ligand Pharmaceuticals
VC Fund
2 United States, Austria, Denmark Post-IPO Debt, Corporate Round, Post-IPO Equity Biotechnology, Medical, Health Care $3M–$90M
Simon Capital
VC Fund
2 Germany, Austria, The Netherlands Seed, Series A, Series B Software, Biotechnology, Health Care $1.7M–$57M
APEX Ventures
VC Fund
2 Germany, United Kingdom, Austria Seed, Series A, Pre-Seed Artificial Intelligence, Software, Health Care $552k–$28M
HTGF (High-Tech Gruenderfonds)
VC Fund
2 Germany, Switzerland, United States Seed, Series A, Pre-Seed Software, Biotechnology, Information Technology $790k–$31M
Nina Capital
VC Fund
2 United States, United Kingdom, Germany Seed, Pre-Seed, Series A Health Care, Artificial Intelligence, Software $529k–$21M
Hadean Ventures
VC Fund
2 Sweden, Norway, Austria Series A, Series B, Venture - Series Unknown Biotechnology, Health Care, Medical $2M–$79M
Longevitytech.fund
VC Fund
2 United States, United Kingdom, The Netherlands Seed, Convertible Note, Pre-Seed Biotechnology, Health Care, Life Science $100k–$10M
Übermorgen Ventures
VC Fund
2 Germany, Switzerland, Finland Seed, Pre-Seed, Series A Energy, Software, SaaS $300k–$12M
TSVC
VC Fund
2 United States, China, Canada Seed, Series A, Venture - Series Unknown Software, Artificial Intelligence, Information Technology $500k–$44M
Aescap Venture
VC Fund
2 Switzerland, United Kingdom, The Netherlands Series B, Series A, Series C Biotechnology, Pharmaceutical, Health Diagnostics $1.5M–$33M
Axilium Holding
VC Fund
2 Sweden, Austria Seed, Venture - Series Unknown Software, Human Resources, FinTech $450k–$7.3M
Schnidar Harald
Angel
2 Austria Seed, Angel, Pre-Seed Software, Biopharma, Cosmetics
bmp Ventures
VC Fund
2 Germany, United States, Austria Seed, Venture - Series Unknown, Series A Software, Information Technology, Manufacturing $162k–$12M
R42 Group
VC Fund
2 United Kingdom, United States, Austria Seed, Pre-Seed, Series A Biotechnology, Health Care, Software $472k–$40M
ICL Planet Startup Hub
VC Fund
2 Israel, Austria Seed Biotechnology, Agriculture, AgTech $4.3M–$10M
MCI Capital SA
VC Fund
2 Poland, United Kingdom, Germany Series A, Venture - Series Unknown, Seed E-Commerce, Software, Financial Services $766k–$29M
Gamma Capital Partners
VC Fund
2 Austria, United States, Germany Series A, Seed Software, Manufacturing, Information Technology $409k–$8M
Verge HealthTech Fund
VC Fund
2 Estonia, Singapore, United States Seed, Pre-Seed, Series A Health Care, Medical, Medical Device $500k–$4.7M
Open Field Capital
VC Fund
2 United States, Austria, Switzerland Venture - Series Unknown, Series A, Seed Artificial Intelligence, Software, Machine Learning $150k–$350M
red-stars.com
VC Fund
2 Austria, Germany Seed, Venture - Series Unknown Software, Biotechnology, Telecommunications $1.1M–$4.4M
VP Venture Partners
VC Fund
2 Austria, Germany, Switzerland Seed, Pre-Seed, Series B Medical, Health Care, Biotechnology $3M–$16M
eQventure
VC Fund
2 Austria, Germany, Switzerland Seed, Series A, Series B Software, Information Technology, Automotive $540k–$13M
Novartis Venture Fund
VC Fund
1 United States, Switzerland, United Kingdom Series B, Series A, Series C Biotechnology, Health Care, Therapeutics $5.1M–$120M
Synthesis Capital
VC Fund
1 United States, Israel, Austria Seed, Series A, Series C Biotechnology, Food and Beverage, Organic Food $7.1M–$23M
HBM Partners
VC Fund
1 United States, Germany, Switzerland Series B, Series C Biotechnology, Medical, Health Care $2.5M–$125M
NovaCapital
VC Fund
1 Italy, Austria Seed, Pre-Seed, Series A Software, Artificial Intelligence, Information Technology
Pace Ventures
VC Fund
1 United States, Germany, Austria Seed, Pre-Seed Software, Biotechnology, Information Technology
Borregaard ASA
VC Fund
1 Austria Seed Biotechnology, Chemical Engineering
Satgana
VC Fund
1 Kenya, France, Austria Pre-Seed, Seed Electronics, B2B, Biotechnology
RKP InnoInvest
VC Fund
1 Austria Seed Biotechnology, Food and Beverage
Tet Ventures
VC Fund
1 United States, Germany, United Kingdom Seed, Pre-Seed Food and Beverage, Biotechnology, E-Commerce
HackCapital
VC Fund
1 United States, Israel, United Kingdom Seed, Pre-Seed, Series A Biotechnology, Food and Beverage, Food Processing
Access all 211 investors in Austria Biotech startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

XISTA Science Ventures
VC Fund · Klosterneuburg, Niederosterreich, Austria · 19 investments in Austria Biotech startups, 12 in the past 12 months

We invest in biotech and deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We are embedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Austria, Germany, France

Investor stats

  • Total investments: 48
  • Round size: Seed $1.8M–$6.9M; Pre-Seed $552k–$1.8M; Series A $5.7M–$20M
  • Lead/follow: 56% lead, 44% follow

Portfolio highlights

  • PureSurf — PureSurf is a green chemistry company that develops bio-based surfactants and antimicrobial solutions for consumer and industrial markets.
  • Rivus Batteries — Rivus is a start-up that serves as the commercialization platform for the aqueous organic flow battery technology.
  • Epitome Therapeutics — Epitome Therapeutics is an early-stage biotechnology company developing CADENCE, a next-generation epigenome editing platform for precise, durable, and context-dependent control of gene expression without altering the underlying DNA sequence, with the aim of establishing a new therapeutic modality for diseases driven by dysregulated gene activity.
Show all investments...

SOSV
VC Fund · Princeton, New Jersey, United States · 13 investments in Austria Biotech startups

SOSV offers pre-seed capital and follow-on financial support to startups focusing on deep technology and scientific innovation. Founders utilize purpose-built laboratory facilities and engineering spaces to accelerate product development and testing. The firm facilitates connections between entrepreneurs and a network of investors through structured matchmaking events and technology summits.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Convertible Note, Pre-Seed
  • Geography: United States, China, Canada

Investor stats

  • Total investments: 3729
  • Round size: Seed $150k–$5M; Pre-Seed $50k–$1.6M; Convertible Note $50k–$3.6M
  • Lead/follow: 37% lead, 63% follow
  • Last fund: Likely still investing — raised $306M in 2023

Portfolio highlights

  • Halla — Halla Intelligence is a digital solution that leverages over 100 billion shopper and product data points to recommend and promote what grocery items.
  • Simply Good Jars — Simply Good Jars is a B-Corp company that delivers healthy meals in reusable + returnable packaging through use of smart refrigerated kiosks placed in offices, transit centers, universities and health-systems. Driven by purpose to change that way people think about consumption, SGJ introduces sustainable business practices into their everydayoperations with a zero-waste goal. For every jar returned back to the company for reuse, they will help feed someone in need and ensure that no packaging materials end up in landfills.
  • Verdex Technologies — Verdex Technologies is an advanced materials platform technology that uses nanofibers to disrupt industries. Verdex doesn't just compete, it innovates and disrupts.
Show all investments...

tecnet equity
VC Fund · Sankt Polten, Niederosterreich, Austria · 9 investments in Austria Biotech startups

Tecnet equity is an Austrian venture capital fund investing in new technology enterprises as well as companies with innovative business ideas through venture capital. As an early-stage investor, tecnet plays an active part in the Austrian start-up landscape for many years. The support tecnet provides goes far beyond a financial investment. With personal commitment, an international business network and many years of experience, tecnet support you in making your business successful. Active in the areas of information and communication technologies (ICT), life sciences, industrial technologies, material sciences and environmental technologies, tecnet equity is providing venture capital during seed and early stages. tecnet equity further supports the management teams of its portfolio companies in developing businesses that are fit for high and sustainable growth. Tecnet also offers comprehensive support to research centres and universities in the analysis, development and marketing of research results as well as patent protection. Inventions that are of value to society are offered to companies for implementation in new products generating additional business opportunities.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Artificial Intelligence
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: Austria

Investor stats

  • Total investments: 76
  • Round size: Seed $400k–$2.5M; Series A $557k–$20M; Venture - Series Unknown $208k–$3.5M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: May invest from a new fund soon — raised $33M in 2009

Portfolio highlights

  • PROPCORN AI — At PROPCORN, our goal is to harness the power of AI to automatically unlock the full real estate building potential of our customers, enabling them to make faster and more accurate decisions in real-time.
  • deepentix — Deepentix provides a graph-as-a-service platform that converts unstructured documents into verifiable claim graphs. Its software extracts semantic claims, qualifiers, constraints, and confidence information, then links entities to domain ontologies. The Claim Graph API supports natural-language and API-based queries with paragraph-level citations,conflict flags, policy checks, and provenance paths. Private extractors use domain-tuned small language models for organization-specific templates and terminology. Deepentix also offers hosted and on-premises graph deployments that can integrate with systems such as electronic laboratory notebooks, laboratory information management systems, claims systems, and chat copilots. The platform is intended for regulated workflows in life sciences, insurance, legal and regulatory work, and climate and ESG analysis where document-based decisions require traceability and audit records.
  • VALANX Biotech — VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development.
Show all investments...

xista science ventures
VC Fund · Klosterneuburg, Niederosterreich, Austria · 9 investments in Austria Biotech startups

We invest in deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We areembedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Austria, Slovenia

Investor stats

  • Total investments: 22
  • Round size: Seed $1.8M–$7.3M; Pre-Seed $552k–$1.5M; Series A $5.7M–$20M
  • Lead/follow: 64% lead, 36% follow

Portfolio highlights

  • subdron — subdron turns the seabed from a blind spot into a monitored domain.
  • infrared.city — Redefine environmental simulations. Our bespoke AI models revolutionise performative design, slashing time, cost, and complexity. Access cutting-edge services effortlessly because innovation should be for everyone
  • VALANX Biotech — VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development.
Show all investments...

austria Wirtschaftsservice (aws)
VC Fund · Vienna, Wien, Austria · 6 investments in Austria Biotech startups, 6 in the past 12 months

The Austrian Economic Service mbH (aws) is the promotional bank of the Federal Government.The aws SME fund is the largest Austrian Fund for silent corporate investments, but also providers of equity. Founded in late 2009 by the Austrian Economic Service mbH (aws) - the Development Bank of the Federal - he has a term until 31/12/2025.The fund is currently endowed with EUR 80 million and participates in medium-sized companies and brings with it a fresh capital to develop new products or processes, for sales development to international expansion.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Grant, Pre-Seed
  • Geography: Austria, Belgium

Investor stats

  • Total investments: 76
  • Round size: Seed $452k–$2.7M; Grant $61k–$2.3M; Pre-Seed $195k–$1.6M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: May invest from a new fund soon — raised $92M in 2013

Portfolio highlights

  • Repentium — We strive to create
  • Graph Therapeutics — Graph Therapeutics - precision immunology
  • Epitome Therapeutics — Epitome Therapeutics is an early-stage biotechnology company developing CADENCE, a next-generation epigenome editing platform for precise, durable, and context-dependent control of gene expression without altering the underlying DNA sequence, with the aim of establishing a new therapeutic modality for diseases driven by dysregulated gene activity.
Show all investments...

aws Gründungsfonds
VC Fund · Vienna, Wien, Austria · 4 investments in Austria Biotech startups

aws Gründerfonds is Austria's 70m venture capital fund. We invest as co-investor in Austrian high-growth start-ups in their later seed and (pre-)series-A stages.

Show more...

Investment focus

  • Industry: Software, SaaS, Information Technology
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: Austria, Germany, United States

Investor stats

  • Total investments: 100
  • Round size: Seed $1.3M–$5.2M; Series A $1.1M–$11M; Venture - Series Unknown $1.9M–$3.4M
  • Lead/follow: 14% lead, 86% follow
  • Last fund: Likely still investing — raised $77M in 2023

Portfolio highlights

  • refinq — refinq scores every one of your locations for physical climate, nature and transition risk under IPCC scenarios, then links exposure to financial impact and adaptation actions.
  • profitize — profitize is an AI‑powered financial planning and analysis (FP&A) platform built specifically for hotels and other hospitality businesses.The platform uses AI to generate forecasts, highlight risks, and provide actionable insights, positioning itself as an “FP&A co‑pilot” for hotel profitability rather than just a reporting tool.
  • Invisible-Light Labs — Invisible Light Labs uses Fourier transform infrared (FTIR) spectroscopy and nanoelectromechanical sensing technologies to enable chemical analysis of materials and nanomaterials that are available in minuscule amounts in a variety of industries, from environmental monitoring to pharmaceuticals.
Show all investments...

MIG Capital
VC Fund · München, Bayern, Germany · 4 investments in Austria Biotech startups

MIG Capital is one of the leading German VC Investors. We invest in European Deep Tech and Life Sciences from early to late stage (Seed, Series A, and beyond). We use investments to shape a better tomorrow, today. Our team currently manages 17 MIG public venture capital funds regulated by BaFin, the German financial markets authority. These funds operate with more than EUR 1.2 billion capital committed by >60,000 private investors across Germany and Austria. Today, our portfolio consists of 30 companies.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Series A, Series B, Venture - Series Unknown
  • Geography: Germany, France, Austria

Investor stats

  • Total investments: 98
  • Round size: Series A $1.9M–$40M; Series B $1.7M–$60M; Venture - Series Unknown $5.6M–$20M
  • Lead/follow: 45% lead, 55% follow
  • Last fund: May invest from a new fund soon — raised $76M in 2014

Portfolio highlights

  • NcodiN — The High Performance Computing (HPC) and ArtificiaI Intelligence (AI) era requires unprecedented computing capabilities. With this in view, industry is heading towards zettascale supercomputers, based on >100k processing units. Chiplets-based disaggregated processors and memory-centric computing architectures are taking over and require an ever more intensive communication between dies. Thus, today interconnect bottleneck is the main
  • GlassPoint Solar — GlassPoint provides solar steam generators to the oil and gas industry for applications such as Enhanced Oil Recovery. It replaces gas-fired steam generation with solar, GlassPoint can reduce EOR gas consumption by up to 80 percent. The company was founded in 2008 and headquartered in Fremont, California.
  • Zadient Technologies — Zadient produces semiconductor manufacturing materials that are critical for the entire silicon carbide (SiC) value chain
Show all investments...

Arax Capital Partners
VC Fund · Vienna, Wien, Austria · 4 investments in Austria Biotech startups

ARAX Capital Partners is an Austrian bio-tech and high-tech early stage investor with an exclusive focus on Austrian ventures. Companies need to be young, innovative (if possible with patentable technology) and must have already secured pre-seed funding to qualify for an investment

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Venture - Series Unknown, Seed, Series A
  • Geography: Austria, United States

Investor stats

  • Total investments: 14
  • Round size: Seed $687k–$1.1M; Venture - Series Unknown $271k–$10M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: May invest from a new fund soon — raised $88M in 2008

Portfolio highlights

  • Greenpass — Greenpass is an all-in-one SaaS for climate-resilient urban planning & architecture platform that enables livable cities.
  • Calyxha Biotechnologies — A new perspective on inflammation
  • EveliQure Biotechnologies GmbH — EveliQure was founded in 2012 with headquarters in Vienna and developed for the first time a combined vaccine, which is intended to protect against Shigella as well as against ETEC bacteria. Both bacterial strains cause various types of diarrheal diseases, and all attempts at development of vaccines have so far only aimed to protect against one ofthe two bacterial strains. The team led by Managing Director Gábor Somogyi has succeeded for the first time in producing a combined swallow vaccine that simultaneously protects against both bacterial strains.
Show all investments...

PUSH VC
VC Fund · Vienna, Wien, Austria · 3 investments in Austria Biotech startups

Early-stage VC. Pre-Seed and Seed stage. We are investing in Health- & Green Tech start-ups with singificant impact and outstanding teams.

Show more...

Investment focus

  • Industry: Software, Apps, Health Care
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Austria, Germany, United States

Investor stats

  • Total investments: 46
  • Round size: Seed $650k–$8.1M; Series A $5M–$31M
  • Lead/follow: 17% lead, 83% follow
  • Last fund: May invest from a new fund soon — raised $11M in 2019

Portfolio highlights

  • Voltrac — To Secure Our Borders and Food Supply.
  • enspired — Revolutionize battery storage with AI-powered BESS optimization. Our energy trading platform ensures smart, real-time market access. Contact us today!
  • Aitiologic — A precision medicine startup providing multi-modal liquid biopsy solutions for early disease detection and targeted therapy.
Show all investments...

FPS-Holding
VC Fund · 3 investments in Austria Biotech startups

Investment focus

  • Industry: Biotechnology, Health Diagnostics
  • Stage:Seed
  • Geography: Austria

Investor stats

  • Total investments: 3
  • Round size: Seed $420k–$1.5M
  • Lead/follow: 100% lead, 0% follow

Portfolio highlights

  • Sola Diagnostics — Product: Sola Diagnostics’ WID®-easy test is a non-invasive epigenetic solution for detecting endometrial cancer in women with abnormal uterine bleeding. By analyzing DNA methylation markers from a simple vaginal swab, it offers high accuracy, reducing false positives and unnecessary surgeries. Target Audience: Designed for gynecologists andhealthcare providers, WID®-easy streamlines diagnostics, cutting costs and false alarms. Women benefit from a painless, accessible test that ensures earlier and more precise detection. Technology: Powered by advanced DNA methylation research, WID®-easy identifies cancer-specific epigenetic markers. With PCR-based analysis and robust clinical validation, it delivers fast, reliable results that integrate seamlessly into medical workflows. Market Positioning: WID®-easy fills a critical gap as a first-line diagnostic for abnormal uterine bleeding. Its clinical validation, accuracy, and cost-efficiency set it apart from invasive procedures. Its ease of use and scalability position it for widespread adoption. Milestones: Sola Diagnostics launched in Austria and Switzerland in 2024 and expanded to Great Britain in 2025. UKCA Marking was registered in December 2024. So far, private equity investments totaling €2.4M have supported Sola's mission to revolutionize women’s health diagnostics.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Lansdowne Partners
VC Fund · London, England, United Kingdom · 3 investments in Austria Biotech startups

Fundamental Equity Investing, since 1998

Show more...

Investment focus

  • Industry: Biotechnology, Information Technology, Finance
  • Stage:Series A, Series B, Series C
  • Geography: United Kingdom, Austria, United States

Investor stats

  • Total investments: 46
  • Round size: Series A $6.7M–$55M; Series B $9.1M–$100M; Series C $19M–$162M
  • Lead/follow: 20% lead, 80% follow
  • Last fund: May invest from a new fund soon — last raise in 2017

Portfolio highlights

  • MoA Technology — We harness the principles of natural selection to accelerate discovery for better, safer herbicides so farmers can continue to feed the world.
  • GALLOS Technologies — GALLOS is a company that co-builds & invests in security technology companies. Guiding security technology innovators to long-term success
  • amnis — Check out your possibilities to transfer money abroad, collect international payments and exchange currencies all in one account. Make payments fast with amnis.
Show all investments...

10x Founders
VC Fund · Munich, Bayern, Germany · 3 investments in Austria Biotech startups

Cutting-edge venture capital firm supporting the early-stage entrepreneurs building global businesses.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Germany, United States, Switzerland

Investor stats

  • Total investments: 94
  • Round size: Seed $2.5M–$10M; Pre-Seed $620k–$5M; Series A $6.7M–$53M
  • Lead/follow: 15% lead, 85% follow
  • Last fund: Likely still investing — raised $168M in 2022

Portfolio highlights

  • Logicc — Logicc provides business solutions for various industries. It specializes in software development, automation, and data-driven technologies.
  • Qorelo — Qorelo is a tech company that provides agentic AI software designed to accelerate ERP transformations. Qorelo's software automates and structures deliverables across the SAP Activate methodology.
  • Arlequin AI — Unlock actionable insights from complex social data to drive strategic decisions using our AI models.
Show all investments...

REVENTON
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 2 investments in Austria Biotech startups

REVENTON is a venture capital firm based in Amsterdam, The Netherlands.

Show more...

Investment focus

  • Industry: Software, InsurTech, Insurance
  • Stage:Venture - Series Unknown
  • Geography: Austria

Investor stats

  • Total investments: 2
  • Round size: Venture - Series Unknown $1.2M–$1.8M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Cortical.io — Cortical.io delivers AI-based solutions that relieve your employees of the burden of reviewing large amounts of documents or sifting through masses of text messages.
Show all investments...

The Austrian Research Promotion Agency (FFG)
VC Fund · Vienna, Wien, Austria · 2 investments in Austria Biotech startups

The Austrian Research Promotion Agency (FFG) is the national funding agency for industrial research and development in Austria. As a "one-stop shop" offering a diversified and targeted programme portfolio, the FFG gives Austrian businesses and research facilities quick and uncomplicated access to research funding.The FFG was foundedon 1 September 2004 (pursuant to the FFG Act on establishing a research promotion agency, Federal Law Gazette I No. 73/2004). The FFG is wholly owned by the Republic of Austria, represented by the Federal Ministry for Transport, Innovation and Technology (bmvit) and the Federal Ministry of Science, Research and Economy (BMWFW). As a provider of funding services, however, the FFG also works for other national and international institutions.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Medical
  • Stage:Grant, Seed, Pre-Seed
  • Geography: Austria, United States, Belgium

Investor stats

  • Total investments: 70
  • Round size: Seed $300k–$2.2M; Grant $67k–$3.5M; Pre-Seed $480k–$1.9M
  • Lead/follow: 27% lead, 73% follow

Portfolio highlights

  • OPTIMUSE — Optimuse provides an AI-based solution that supports the pre-design phase of building renovation. The platform converts building data into a digital twin to create accurate models for planning. It integrates data such as room types, thermal properties, and HVAC systems. The system runs energy simulations to calculate heating, cooling, lighting, andequipment needs. It helps design technical systems by defining the quantity, sizing, and configuration of components. The platform develops renovation plans by modeling financial, energy, and emissions outcomes. It also offers tools for cost calculation, performance monitoring, and collaboration across project teams.
  • sequestra — Sequestra is developing a technology platform that allows for permanent binding of CO₂ in industrial residues such as steel slag, incineration ash, and demolition waste while making the carbonated materials usable for construction applications.
  • Another Earth — Another Earth is building an AI-powered simulation and synthetic data platform for Earth Observation. As our planet changes, AI models need scalable, high-quality training data to keep pace. Another Earth provides synthetic data, scenario simulations and predictions required to accelerate AI development, and enable faster, smarterdecision-making—enabling smarter decisions for a more resilient world.
Show all investments...

SkyGene
VC Fund · Austria, Pangasinan, Philippines · 2 investments in Austria Biotech startups

SkyGene is a venture capital firm. The firm intends to invest in biotech firms.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Venture - Series Unknown
  • Geography: Austria

Investor stats

  • Total investments: 2
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • VALANX Biotech — VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development.
Show all investments...

BackBone Ventures
VC Fund · Zurich, Zurich, Switzerland · 2 investments in Austria Biotech startups

BackBone Ventures' focus are early-stage investments, primarly in the area of innovative ICT, FoodTech and disruptive technologies in DACH & Israel. Committed to achieve a positive impact for the next generation by empowering access to proficient ventures investments.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Information Technology
  • Stage:Pre-Seed, Seed, Series A
  • Geography: Switzerland, Germany, Israel

Investor stats

  • Total investments: 74
  • Round size: Seed $966k–$4M; Pre-Seed $578k–$2.8M; Series A $5M–$105M
  • Lead/follow: 26% lead, 74% follow

Portfolio highlights

  • eternal.ag — We help greenhouses overcome labor shortages through autonomous harvesting robots so they can keep operations running, every day, at scale.
  • Immitra Bio — Developing scalable in-vivo genomic medicine for blood disorders
  • NextBusiness — Die einfache Schweizer Buchhaltung, mit der du buchen und Rechnungen schreiben kannst. Mit der praktischen KI-Buchhaltung buchst du 58% schneller.
Show all investments...

KHAN Technology Transfer Fund
VC Fund · Dortmund, Nordrhein-Westfalen, Germany · 2 investments in Austria Biotech startups

KHAN Technology Transfer Fund operates as an investment firm.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Biopharma
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Germany, Austria, Belgium

Investor stats

  • Total investments: 15
  • Round size: Seed $259k–$10M; Series A $5.6M–$10M
  • Lead/follow: 53% lead, 47% follow

Portfolio highlights

  • iDEL Therapeutics — iDEL Therapeutics is advancing a new class of cancer medicines by delivering therapeutic payloads directly into the cytosol of tumor cells through a unique, pan-cancer uptake mechanism.
  • KyDo Therapeutics — KyDo Therapeutics is a biotechnology company that develops novel covalent-allosteric small molecule inhibitors.
  • Revier Therapeutics — Revier Therapeutics is a biotechnology company focused on developing innovative solutions to improve human health and treat diseases.
Show all investments...

GreyBird Ventures
VC Fund · Concord, Massachusetts, United States · 2 investments in Austria Biotech startups

GreyBird Ventures medical technology firm and invests in companies developing products for precision medicine.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Seed
  • Geography: United States, Germany, China

Investor stats

  • Total investments: 11
  • Round size: Seed $3M–$5M; Series A $3M–$16M
  • Lead/follow: 91% lead, 9% follow

Portfolio highlights

  • NeuroKaire — Genetika+ is revolutionzing depression treatment. Using biological, medical and genetic data, GenetikaPlus develops personalized solution for every patient to help them recover better, faster.
  • Platomics — Platomics provides a regulatory compliant digital infrastructure and network for every laboratory to setup and run genetic tests.
  • Angstrom Bio — Machine Intelligence for Human Health. We apply machine learning and novel nucleotide chemistry to the study, diagnosis, and treatment of disease.
Show all investments...

Ligand Pharmaceuticals
VC Fund · San Diego, California, United States · 2 investments in Austria Biotech startups

A genetic medicines company developing first-in-class, non-viral, targeted nucleic acid therapeutics utilizing a proprietary gene monoclonal antibody (GMAB) platform technology.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Post-IPO Debt, Corporate Round, Post-IPO Equity
  • Geography: United States, Austria, Denmark

Investor stats

  • Total investments: 21
  • Round size: Post-IPO Debt $15M–$85M; Corporate Round $3M–$10M; Post-IPO Equity $15M–$90M
  • Lead/follow: 57% lead, 43% follow

Portfolio highlights

  • AvenCell — Next generation immunotherapies for hard-to-treat cancers that are allogeneic and switchable.
  • Primrose Bio — Primrose Bio is a biotech company that focuses on discovery, development, and manufacturing of new molecules. innovative therapeutics, vaccines and ingredients to aevance global health.
  • Castle Creek Biosciences — Dedicated to making life better for people suffering from rare diseases with few or no treatment options
Show all investments...

Simon Capital
VC Fund · Düsseldorf, Nordrhein-Westfalen, Germany · 2 investments in Austria Biotech startups

Simon Capital is an early-stage VC fund with €105M capital ready to invest in innovations that will improve our everyday lives, following the mission of investing “for the next generation”.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: Germany, Austria, The Netherlands

Investor stats

  • Total investments: 22
  • Round size: Seed $1.8M–$9.3M; Series A $1.7M–$14M; Series B $32M–$57M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: Likely still investing — raised $110M in 2022

Portfolio highlights

  • VisioLab — Instantly scan products for self-checkout, using the iPad camera - no barcodes needed. Designed for speed, simplicity and human centricity.
  • Pacifico Biolabs — Pacifico Biolabs offers fermentation biotechnology for development, production and distribution of sustainable and food alternatives.
  • dsb Deutsche Sanierungsberatung — dsb Deutsche Sanierungsberatung provides easy and sustainable solutions for climate-friendly homes energy-efficient renovations for homeowners.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
APEX Ventures
VC Fund · Vienna, Wien, Austria · 2 investments in Austria Biotech startups

APEX Ventures is a deep-tech and medical focused venture capital firm, run by founders with complimentary backgrounds driven by the same mission.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Health Care
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Germany, United Kingdom, Austria

Investor stats

  • Total investments: 62
  • Round size: Seed $1.4M–$8M; Pre-Seed $552k–$9.1M; Series A $5.7M–$28M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: May invest from a new fund soon — last raise in 2020

Portfolio highlights

  • Quibim — Quibim builds AI tools that turn MRI, CT and PET data into actionable predictions for hospitals and biopharma. Trusted in 470+ centers worldwide.
  • iPremom — iPremom is a healthcare technology company that develops molecular diagnostic solutions for the early detection and prediction of pregnancy complications, particularly preeclampsia.
  • Jago Coffee — Jago Coffee serves freshly brewed coffee beverages wherever you are through a fleet of fully electric mobile cafes.
Show all investments...

HTGF (High-Tech Gruenderfonds)
VC Fund · Bonn, Nordrhein-Westfalen, Germany · 2 investments in Austria Biotech startups

High-Tech Grunderfonds finances startups with growth potential. Its team of investment managers supports young companies with expertise, entrepreneurial spirit, and passion. The company focuses in the fields of digital tech, industrial tech, life sciences, chemistry, and related business areas. It also focuses on financial services in various sectors.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Information Technology
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Germany, Switzerland, United States

Investor stats

  • Total investments: 781
  • Round size: Seed $790k–$6.9M; Pre-Seed $841k–$2.8M; Series A $3M–$31M
  • Lead/follow: 34% lead, 66% follow
  • Last fund: Likely still investing — raised $515M in 2022

Portfolio highlights

  • Selfapy — Selfapy offers a therapy support tool that helps recognize negative patterns of thought and train new behavior. Selfapy is your guided, self-help online course against depression with a personal psychologist as a companion.
  • Smartblue — Smartblue develops and runs software and processes to monitor and optimize zero emission energy systems. As a hardware independent specialist Smartblue delivers a software service for the maintenance, life-cycle management, production forecasting and remote control of photovoltaic and energy storage systems all together in one centralized “SmartControl” Operations and Control Center web application. We help our customers drive down overall operational cost through automation, smart failure detection and big data analysis on imminent defects.
  • OMEICOS Therapeutics — OMEICOS Therapeutics is developing a novel, first-in-class, small molecule utilizing a new Mode of Action. OMEICOS' novel therapeutic strategy is based upon the discovery of natural metabolites of omega-3 fatty acids that mediate a strong anti-arrhythmic effect. In contrast to all other anti-arrhythmic drugs, OMEICOS' substances activatean endogenous cardio-protective signaling pathway that not only stabilizes the heart rhythm but shall provide curative effects to the diseased organ by preventing its electrical and structural remodeling.
Show all investments...

Nina Capital
VC Fund · Barcelona, Catalonia, Spain · 2 investments in Austria Biotech startups, 6 in the past 12 months

We deploy early stage capital to fuel the growth of need-driven health technology companies.

Show more...

Investment focus

  • Industry: Health Care, Artificial Intelligence, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 96
  • Round size: Seed $2M–$6.3M; Pre-Seed $529k–$2.4M; Series A $5M–$21M
  • Lead/follow: 43% lead, 57% follow
  • Last fund: Likely actively investing — fresh fund, raised $52M in 2025

Portfolio highlights

  • Biobase — Biobase is the agentic system for clinical data, closing the gap between clinical data and better healthcare.
  • Ladder Health — Expert speech, occupational, physical, and feeding therapy for children, right from home, with flexible virtual visits and a plan that fits real life.
  • Woodway Assurance — Woodway Assurance provides EviData, an AI-driven software for automated privacy assurance on de-identified and synthetic datasets.
Show all investments...

Hadean Ventures
VC Fund · Oslo, Oslo, Norway · 2 investments in Austria Biotech startups

Hadean Ventures is a life science fund manager that invests in life science companies across europe with a particular focus on the nordic region. The funds are backed by leading private and institutional investors. Hadean Ventures has offices in oslo and stockholm and collaborates with world-class academic institutions and start-up hubs across the region

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Venture - Series Unknown
  • Geography: Sweden, Norway, Austria

Investor stats

  • Total investments: 36
  • Round size: Series A $4.2M–$79M; Series B $4.5M–$75M; Venture - Series Unknown $2M–$29M
  • Lead/follow: 50% lead, 50% follow
  • Last fund: May invest from a new fund soon — raised $168M in 2021

Portfolio highlights

  • Oncoinvent — Oncoinvent AS designs and develops cancer treatments by applying known physical and chemical principles of selected novel materials in new ways in order to maximize their medical benefit while minimizing potential safety concerns.
  • Kasvu Therapeutics — Kasvu develops first and best-in-class small molecule neuroplastogens for diseases where neuronal connectivity is altered
  • TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
Show all investments...

Longevitytech.fund
VC Fund · Prague, Hlavni mesto Praha, Czech Republic · 2 investments in Austria Biotech startups

Investing globally in technologies extending healthy lifespans

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Life Science
  • Stage:Seed, Convertible Note, Pre-Seed
  • Geography: United States, United Kingdom, The Netherlands

Investor stats

  • Total investments: 56
  • Round size: Seed $634k–$10M; Pre-Seed $100k–$3.6M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Whytics — DAGI: higher-level causal models from spatiotemporal coarse‑graining Whytics builds tools to reveal and validate macro‑causal structure—the stable, higher-level variables that appear when many parts of a system interact across space and time.
  • Klothea Bio — Klothea Bio is a protein well known for its powerful anti-aging capabilities, such as tumor suppression, neuroprotection, and antioxidative actions. As people age, their klotho levels drop to harmful levels. The metabolic disease syndrome will be the focus of the first investigations, while later studies will try to extend therapeutic applicationsto cancer, Alzheimer's disease, obesity, and other age-related diseases.
  • Yuva Biosciences — Using cutting edge mitochondrial science to develop cosmeceuticals and pharmaceuticals.
Show all investments...

Übermorgen Ventures
VC Fund · Zürich, Zurich, Switzerland · 2 investments in Austria Biotech startups

We are an early stage VC for climate tech startups.

Show more...

Investment focus

  • Industry: Energy, Software, SaaS
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Germany, Switzerland, Finland

Investor stats

  • Total investments: 55
  • Round size: Seed $2.1M–$5.9M; Pre-Seed $300k–$4.1M; Series A $2.5M–$12M
  • Lead/follow: 22% lead, 78% follow

Portfolio highlights

  • Ecair — Ecair provides software for indoor air quality and energy management. The platform aggregates data from connected sensors to track pollutants, CO2, humidity, temperature, and particulate matter in real time. Dashboards, alerts, and APIs support building operations, facility managers, and ESG teams. Algorithms estimate exposure, flag ventilationissues, and suggest HVAC adjustments to balance comfort, health, and energy use. Reporting tools support certifications and compliance, and data exports integrate with BMS, CMMS, and data warehouses. Services include device provisioning, calibration management, and analytics consulting for multi-site portfolios.
  • Verna — Verna is a business using geospatial data science to address the climate and nature crises.We help landowners, investors, and policymakers to use land in ways that draw down carbon, enhance biodiversity and generate sustainable returns – e.g. through woodland creation, habitat creation and enhancement, and regenerative agriculture.Verna wasestablished in Borehamwood, Hertford.
  • Hyperion Robotics — We are accelerating the transition to sustainable and automated construction with Concrete 3D Printing.
Show all investments...

TSVC
VC Fund · Los Altos, California, United States · 2 investments in Austria Biotech startups, 10 in the past 12 months

Founded in 2010, TSVC (formerly TEEC Angel Fund) is proud to be a leading early-stage venture capital fund in Silicon Valley.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: United States, China, Canada

Investor stats

  • Total investments: 366
  • Round size: Seed $500k–$6.3M; Series A $2M–$44M; Venture - Series Unknown $1M–$41M
  • Lead/follow: 7% lead, 93% follow
  • Last fund: Likely actively investing — fresh fund, raised $20M in 2026

Portfolio highlights

  • Dexmate — Vega 1 Pro is a general-purpose wheeled humanoid on Dexmate's Physical AI platform. One robot for the whole job, from research labs to factory floor.
  • EGI Battery — EGI Battery designs and manufactures advanced lithium-ion pouch cells in Ann Arbor, Michigan, with NDAA-compliant domestic production starting in 2027.
  • Expert Intelligence — Expert Intelligence develops AI systems to scale expert decision-making in regulated laboratory conditions where data is restricted, stakes are high, and validation is required.
Show all investments...

Aescap Venture
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 2 investments in Austria Biotech startups

Aescap Venture is an Amsterdam-based investment company that pursues investments in biotech companies in Europe and the U.S.

Show more...

Investment focus

  • Industry: Biotechnology, Pharmaceutical, Health Diagnostics
  • Stage:Series B, Series A, Series C
  • Geography: Switzerland, United Kingdom, The Netherlands

Investor stats

  • Total investments: 20
  • Round size: Series A $1.5M–$20M; Series B $5.2M–$33M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: May invest from a new fund soon — last raise in 2016

Portfolio highlights

  • Strategic Partners — Orphazyme develops innovative new therapies for the treatment of a family of serious genetic disordes called lysosomal storage diseases, and is based on discoveries emerging from the academic laboratory of its scientific founders: Professor Marja Jäättela and Thomas Kirkegaard Jensen from the Danish Cancer Society (Kræftens Bekæmpelse).Orphazyme is based in Copenhagen and has established collaborations with top-tier academic institutions in Europe and USA.
  • Affectis Pharmaceuticals — Affectis is a pharmaceuticals company developing novel drugs for the treatment of neurodegenerative and neuroinflammatory diseases.
  • F-Star Therapeutics — F-star is a clinical stage biotech developing next generation immunotherapies to transform the lives of patients with cancer. We are developing transformational cancer immunotherapies for patients who have few remaining options.
Show all investments...

Axilium Holding
VC Fund · 2 investments in Austria Biotech startups

Axilium Holding

Show more...

Investment focus

  • Industry: Software, Human Resources, FinTech
  • Stage:Seed, Venture - Series Unknown
  • Geography: Sweden, Austria

Investor stats

  • Total investments: 4
  • Round size: Seed $450k–$7.3M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Planacy — Planacy is a modern and flexible planning platform that is built to handle a complex reality. With Planacy you will get a tailor-made platform that is adjusted just for your business needs, a platform that you can easily develop when your prerequisites changes. By smart and seamless integrations to your BI platforms from Power BI®, Qlik® orTableau®, Planacy decreases the time consuming manual and repetitive work and supports your business with a fast, safe, more collaborative and flexible process. Together with an intuitive and smooth user interface your planning process will be simpler and more fun with more time to spend on the more value creating work as a result.
  • Sarcura — Sarcura GmbH is an Austrian deep-tech startup developing an instrument platform for the industrial manufacturing of advanced cell therapies. Our platform combines silicon chip technology and microfluidic processing to enable real-time process control and manipulation on a cellular level, enabling a fully automated and modular manufacturing system..
  • WorkNode — Worknode is shaping the future of work. With modern technology and a deep understanding of labor market dynamics, we make flexible work safe, simple, and sustainable for both individuals and companies.For individuals, Worknode enables earning and getting paid like an employee without starting a company. For businesses, we provide a digitalemployer-of-record service that streamlines the management of external talent with full compliance, transparency, and efficiency.By building the digital infrastructure for a more flexible workforce, Worknode creates new opportunities for people to shape their careers and for companies to scale with the right skills at the right time. More than a platform, Worknode is a partner in driving a modern, dynamic, and inclusive way of working.
Show all investments...

Schnidar Harald
Angel · Vienna, Wien, Austria · 2 investments in Austria Biotech startups

Entrepreneur, Angel Investor, Scientist and Inventor

Show more...

Investment focus

  • Industry: Software, Biopharma, Cosmetics
  • Stage:Seed, Angel, Pre-Seed
  • Geography: Austria

Investor stats

  • Total investments: 7
  • Lead/follow: 86% lead, 14% follow

Portfolio highlights

  • SCARLETRED — SCARLETRED is an international Digital Health Scaleup revolutionising the global skin care market by the AI powered SCARLETRED®VISION platform system. The problem we solved is subjective skin assessment and lacking standardization in Dermatology. Our medical device certified platform is fully mobile, runs via mobile App on smartphones and connectsto our web platform, which enables to generate smart imaging data and novel AI decision support applications in Dermatology and Telemedicine. The multi award winning technology is supplied international via SaaS to Biopharma and Cosmetics Industry, Hospitals and Medical Experts. Protected via worldwide patents it facilitates standardized skin documentation and remote tracking of skin changes and therapeutic effects via mobile App. Images can be uploaded in a cloud based platform and objectively analysed for visual skin changes over time, such as for allergic reactions, pigmentation changes, acne, psoriasis, disease or wound healing. SCARLETRED provides services on a broad range of dermatologic conditions ranging from B2B to B2B2C applications.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
bmp Ventures
VC Fund · Berlin, Berlin, Germany · 2 investments in Austria Biotech startups, 7 in the past 12 months

bmp Ventures is an innovative Venture Capital Company from Berlin. Since 1997 we’ve been investing Smart Money in Early Stage and Growth Startups. We finance ingenious business models with outstanding teams, who build fast-growing and sustainably profitable enterprises.

Show more...

Investment focus

  • Industry: Software, Information Technology, Manufacturing
  • Stage:Seed, Venture - Series Unknown, Series A
  • Geography: Germany, United States, Austria

Investor stats

  • Total investments: 122
  • Round size: Seed $162k–$3.6M; Series A $912k–$5.9M; Venture - Series Unknown $172k–$12M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: Likely still investing — raised $70M in 2024

Portfolio highlights

  • Lab Thunder — LabThunder provides a cloud-based laboratory management software platform designed to digitize operational workflows. The system centers on centralizing equipment management, automated maintenance scheduling, digital logbooks, and AI-supported knowledge management to ensure audit-ready compliance.
  • Sedivention — Fight obesity within 20 minutes - fast, effective, long-term. A new weight-loss therapy for the treatment of obesity. Just a view minutes will change your life.
  • Solar Materials — Solar Materials primarily engages in the development of technologies for the sustainable and economical recycling of solar modules.
Show all investments...

R42 Group
VC Fund · Stanford, California, United States · 2 investments in Austria Biotech startups

R42 Group is a venture fund and an institute which invents, invests and informs covering AI, deep science, 5G mobile, biotech and fintech.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, United States, Austria

Investor stats

  • Total investments: 35
  • Round size: Seed $754k–$8M; Pre-Seed $472k–$2M; Series A $4.2M–$40M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: Likely actively investing — fresh fund, raised $5.3M in 2025

Portfolio highlights

  • xWatts — xWatts is an intelligent energy management software that reduces energy costs and emissions in commercial buildings.
  • Stamp Free — stampfree.ai Digital Shipping Solutions enables customers to send parcels and returns with just a phone conveniently and securely.
  • Cordance Medical — We are doing some work on our site. Please come back later. We'll be up and running in no time.
Show all investments...

ICL Planet Startup Hub
VC Fund · Tel Aviv, Tel Aviv, Israel · 2 investments in Austria Biotech startups

ICL Startup Accelerator focuses on foodtech and crop nutrition startups, innovative products, and accelerates their market penetration

Show more...

Investment focus

  • Industry: Biotechnology, Agriculture, AgTech
  • Stage:Seed
  • Geography: Israel, Austria

Investor stats

  • Total investments: 4
  • Round size: Seed $4.3M–$10M
  • Lead/follow: 100% lead, 0% follow

Portfolio highlights

  • Agrematch — Agrematch is a data driven small molecules product discovery, development and marketing company, catering to the agricultural industry. Our novel Ag products discovery engine utilizes big-data science, biology, chemistry, and ag know-how to bring new crop protection products to market.
  • Lavie bio — LaVie Bio develops bacterial compositions that are sprayed on plants, used to coat seeds, or are integrated in the soil around the plant in order to improve the crop or the plant's features.
  • Arkeon Biotechnologies — Arkeon converts CO2 into resources to power tomorrow's industries.
Show all investments...

MCI Capital SA
VC Fund · Warsaw, Mazowieckie, Poland · 2 investments in Austria Biotech startups

MCI Capital is a leading Digital Private Equity investor in CEE, based in Warsaw, Poland. MCI Capital seeks to invest in digital disruption, transformation and infrastructure within EU, with focus on CEE. Preferred sectors are SaaS, E-commerce, Marketplace, Fintech, Insurtech, Foodtech, Traveltech and Digital Infrastructure. MCI typically invests EUR 25-100 M in a single project, either in Buyout or Expansion stage. Historically, MCI Capital has also been involved in funds dedicated to Private Debt, Growth and Venture Capital areas – these funds do not conduct any new investments, instead they focus on building the value of assets and de-investing. MCI Capital is managed by the executive management team. The company is listed on the Warsaw Stock Exchange since February 2001 and is also a member of the Polish Private Equity Association.

Show more...

Investment focus

  • Industry: E-Commerce, Software, Financial Services
  • Stage:Series A, Venture - Series Unknown, Seed
  • Geography: Poland, United Kingdom, Germany

Investor stats

  • Total investments: 61
  • Round size: Seed $1.3M–$1.5M; Series A $766k–$9.6M; Venture - Series Unknown $798k–$29M
  • Lead/follow: 61% lead, 39% follow
  • Last fund: May invest from a new fund soon — raised $15M in 2011

Portfolio highlights

  • Windeln.de — windeln.de, together with its subsidiaries, operates as an online retailer of products for babies, toddlers, children, and young mothers in Germany, Austria, Switzerland, the Czech Republic, Spain, and China. It operates through German Shop, International Shops, and Shopping Clubs segments. The company offers a range of products, including diapers,baby food, drugstore products, clothes, toys, strollers, child car seats, baby monitors, and children’s furniture.
  • ANSWEAR.com — 200 fashion brands with free delivery in 24h!
  • Telematics Technologies — Telematics Technologies sp. z o.o., a Polish technology company, until December 2017 operating as NaviExpert sp. z o.o. The company is a leading provider of insurance telematics and premium navigation solutions for smartphones on the Polish market. The company's portfolio also includes, among others, a system for managing fleets of vehiclesup to 3.5 tonnes called NaviExpert Telematics. In terms of telematics insurance, since 2015 Telematics Technologies has been working with PZU Group, which is one of the largest financial groups in Central and Eastern Europe. As a result of cooperation between the entities, the first offers of Usage-Based Insurance appeared on the Polish market (Safe driving with LINK4, LINK4 Cash Returns) as well as offers of accident detection and reconstruction (PZU GO). Individual customers know Telematics Technologies primarily as a navigation application provider NaviExpert. The application is available on the market under its own brand, as well as in a white label model in offers of all mobile network operators in Poland as Navigation Orange, Navigation Play, Navigation Plus, Navigation T-Mobile. Every month, the system is used by nearly 600 thousand paying users. The company creates solutions that aim to increase road safety by improving drivers' driving styles. Since 2012, the company's CEO has been Adam Bąkowski. The majority shareholder of Telematics Technologies company is Noble Fund Private Debt Fundusz Inwestycyjny Zamknięty Aktywów Niepublicznych with its registered office in Warsaw.
Show all investments...

Gamma Capital Partners
VC Fund · Vienna, Wien, Austria · 2 investments in Austria Biotech startups

gcp gamma capital partners is an independent Venture Capital investment firm, focused on financing dynamic technology companies in Austria, Germany, Switzerland and CEE countries. They seek to achieve superior returns by finding assets with substantial potential in their regional and sectoral focus areas, before they appear on the radar screen of mainstream players in terms of stage and/or initial investment size.

Show more...

Investment focus

  • Industry: Software, Manufacturing, Information Technology
  • Stage:Series A, Seed
  • Geography: Austria, United States, Germany

Investor stats

  • Total investments: 29
  • Round size: Seed $409k–$3M; Series A $1.3M–$8M
  • Lead/follow: 21% lead, 79% follow
  • Last fund: May invest from a new fund soon — last raise in 2010

Portfolio highlights

  • Fatfoogoo — Sudos.com is a super domain system empowering your domaining workflow and automate your market sale listings.
  • Infoniqa Group — The Infoniqa Group combines twenty years of IT experience and a new, trend-setting business, which enables networking advantages and which corresponds to the requirements of their customers - typically international medium and large enterprises and institutions.
  • GAT Microencapsulation — OMPONG188 menjadi tempat untuk mengakses halaman resmi game online melalui link alternatif bebas IP yang banyak disukai oleh para pengguna hiburan digital.
Show all investments...

Verge HealthTech Fund
VC Fund · Singapore, Central Region, Singapore · 2 investments in Austria Biotech startups

We make early investments in global healthcare technology companies that address prevention, disease management and health system efficiency that are relevant to emerging Asia​We believe that innovation can happen anywhere, from the streets of Dhaka to the labs of Oxford, however without the right support network, these solutions might notscale, or find the best world-changing application. This is where we can help.

Show more...

Investment focus

  • Industry: Health Care, Medical, Medical Device
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Estonia, Singapore, United States

Investor stats

  • Total investments: 30
  • Round size: Seed $500k–$4.7M; Pre-Seed $520k–$1M
  • Lead/follow: 57% lead, 43% follow
  • Last fund: Likely still investing — raised $250k in 2023

Portfolio highlights

  • THINKMD — THINKMD develops next-generation clinical assessment and data analytics platforms that transform point-of-care medicine by putting medically validated clinical assessment capability into the hands of non-healthcare professionals. This technology allows for the decentralization of healthcare delivery into communities and homes by pairing clinicalknowledge and Bayesian/pattern recognition algorithms with simple to use mobile technology. Its goal is to reinvent the healthcare delivery paradigm, reduce costs, and improve outcomes by improving healthcare access and care-seeking behavior while building a public health knowledge database.
  • Understanding Zoe — One calm home that remembers for you, for a whole life. Built in Australia for neurodivergent adults and families. Try free for 7 days.
  • Neuraworx Medical Technology — Neuraworx Medical Technology is a neurotechnology company developing first-in-class bioelectronic solutions for brain health.
Show all investments...

Open Field Capital
VC Fund · New York, New York, United States · 2 investments in Austria Biotech startups

Open Field Capital

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Machine Learning
  • Stage:Venture - Series Unknown, Series A, Seed
  • Geography: United States, Austria, Switzerland

Investor stats

  • Total investments: 34
  • Round size: Seed $3.1M–$30M; Series A $4.7M–$350M; Venture - Series Unknown $150k–$6.2M
  • Lead/follow: 0% lead, 100% follow
  • Last fund: Likely actively investing — fresh fund, raised $2.3M in 2024

Portfolio highlights

  • Groq — Groq is a technology company that designs and provides specialized artificial intelligence compute solutions focused on accelerating AI inference workloads using its custom-built Language Processing Unit (LPU) hardware and associated software stack. The company’s core products include purpose-designed silicon and cloud-accessible platforms thatsupport real-time execution of large language models and other AI tasks with low latency and high throughput, enabling developers and enterprises to integrate AI services into production environments efficiently. Groq also delivers cloud-based services that allow customers to access inference capabilities via APIs compatible with popular development tools, supporting seamless integration into existing AI workflows. Its engineering efforts emphasise deterministic performance and streamlined deployment, targeting use cases where speed and cost predictability are critical. Groq engages with partners and customers across sectors that require rapid AI inferencing, and the company’s technology has attracted significant strategic interest and investment within the broader AI infrastructure ecosystem.
  • Numenta — Numenta has developed a cohesive theory, core software technology, and numerous applications all based on principles of the neocortex. This technology lays the groundwork for the new era of machine intelligence. Our innovative work delivers breakthrough capabilities and demonstrates that a computing approach based on biological learning principleswill make possible a new generation of capabilities not possible with today’s programmed computers.
  • Paragraf — We Work to Develop Innovative and Useful End Products from Novel Materials. Our Analogue Sensors Are Designed to Provide Accurate Field Gradient Mapping & Alignment.
Show all investments...

red-stars.com
VC Fund · 2 investments in Austria Biotech startups

We back B2B software and life-sciences companies with limitless scalability.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Telecommunications
  • Stage:Seed, Venture - Series Unknown
  • Geography: Austria, Germany

Investor stats

  • Total investments: 11
  • Round size: Seed $1.1M–$4.4M
  • Lead/follow: 82% lead, 18% follow

Portfolio highlights

  • Txture — IBM Consulting uses IBM Txture to help organizations assess application portfolios, plan cloud modernization and build data-driven transformation strategies.
  • HeartBeat.bio — HeartBeat.bio is a privately funded drug discovery company focusing on the development of a high-throughput 3D screening platform for heart failure and cardiomyopathies.
  • MAVOCO — We create a carrier-grade software for IoT champions, trusted by tier-1 Mobile network operators.
Show all investments...

VP Venture Partners
VC Fund · Zürich, Zurich, Switzerland · 2 investments in Austria Biotech startups

VP Venture Partners is a venture capital firm invests in healthcare companies.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Seed, Pre-Seed, Series B
  • Geography: Austria, Germany, Switzerland

Investor stats

  • Total investments: 7
  • Round size: Seed $3M–$6.9M; Series B $7.5M–$16M
  • Lead/follow: 29% lead, 71% follow

Portfolio highlights

  • Diamens — Diamens is a company focused on femtech that develops a non-invasive menstrual blood-based molecular diagnostic to detect women-specific diseases like endometriosis.
  • Moonlight AI — Moonlight AI was created to democratize the access to genomic information that is essential for therapy decision making in the era of personalized medicine.
  • CollimateHealth — CollimateHealth is creating a clinically scalable microbeam radiation technology that will revolutionize the treatment of cancer.
Show all investments...

eQventure
VC Fund · Graz, Steiermark, Austria · 2 investments in Austria Biotech startups

Entrepreneurs for Entrepreneurs

Show more...

Investment focus

  • Industry: Software, Information Technology, Automotive
  • Stage:Seed, Series A, Series B
  • Geography: Austria, Germany, Switzerland

Investor stats

  • Total investments: 67
  • Round size: Seed $540k–$1.2M; Series A $781k–$5.6M; Series B $4.2M–$13M
  • Lead/follow: 78% lead, 22% follow

Portfolio highlights

  • Diamens — Diamens is a company focused on femtech that develops a non-invasive menstrual blood-based molecular diagnostic to detect women-specific diseases like endometriosis.
  • Respory — Make customer behaviour visible across your store and turn real customer journeys and interactions into better retail decisions.
  • 2nd Cycle — 2nd Cycle creating a cost-effective, fully automated, and scalable solution for modules for a second life cycle.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Novartis Venture Fund
VC Fund · Basel, Basel-Stadt, Switzerland · 1 investments in Austria Biotech startups

Learn about the approach the Novartis Venture Fund takes to investing in innovative life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Series A, Series C
  • Geography: United States, Switzerland, United Kingdom

Investor stats

  • Total investments: 213
  • Round size: Series A $5.1M–$81M; Series B $11M–$120M; Series C $9M–$75M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: May invest from a new fund soon — raised $200M in 2009

Portfolio highlights

  • Splice Bio — Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations ofadeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.
  • Bionano Genomics — Discover how Bionano is striving to elevate health and wellness for all through optical genome mapping (OGM) solutions that transform the way the world sees the genome.
  • LOQUS23 THERAPEUTICS — LoQus23 is a DDF-formed company focussing on targeting DNA damage repair pathways to treat Huntington’s disease and other triplet repeat diseases.
Show all investments...

Synthesis Capital
VC Fund · London, England, United Kingdom · 1 investments in Austria Biotech startups

Synthesis Capital is an investment manager transforming our food system through food technology.

Show more...

Investment focus

  • Industry: Biotechnology, Food and Beverage, Organic Food
  • Stage:Seed, Series A, Series C
  • Geography: United States, Israel, Austria

Investor stats

  • Total investments: 10
  • Round size: Seed $7.1M–$9M; Series A $20M–$23M
  • Lead/follow: 60% lead, 40% follow

Portfolio highlights

  • Triplebar — Triplebar provides sustainability, biotechnology, and synthetic biology research.
  • Savor — Savor makes delightfully rich foods without animals, farmland, fertilizers, hormones, or antibiotics.
  • Culture Biosciences — Culture Biosciences develops automated bio-reactor that helps biotech companies optimize their manufacturing processes and brings products to market faster. The company also builds automated tools for fermentation. It has a digital bio-manufacturing platform to enable scientists to run, monitor, and analyze bio-reactors faster than traditionalapproaches by robotic sample handling and cloud data monitoring and analysis.Culture Biosciences was founded in 2016 and is headquartered in San Francisco, California.
Show all investments...

HBM Partners
VC Fund · Zug, Zug, Switzerland · 1 investments in Austria Biotech startups

HBM Partners focuses on venture, growth and buy-out financings of private companies as well as investments in public companies.The HBM funds invest in entrepreneurial biopharma and other healthcare-related companies in Europe, North America, India and other Emerging Markets. Their team supports the growth of the portfolio companies through allstages of development, focusing on adding value by leveraging its experience and HBM's world-wide network in the industry. Investments usually range between $5 million to $50 million.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Series B, Series C
  • Geography: United States, Germany, Switzerland

Investor stats

  • Total investments: 41
  • Round size: Series B $7.7M–$125M; Series C $2.5M–$113M
  • Lead/follow: 17% lead, 83% follow
  • Last fund: May invest from a new fund soon — raised $105M in 2012

Portfolio highlights

  • Dren Bio — Dren Bio is a biotechnology company with a portfolio of attractive projects focused on powerful protein engineering technologies for the depletion of cells, protein aggregates, and other disease-causing agents. It is a holding company business model aimed at creating value with multiple projects as stand-alone assets.
  • AtaiBeckley — We are a clinical-stage biopharmaceutical company developing new mental health treatments to transform patient outcomes.
  • Mineralys Therapeutics — Evolving science is revealing the importance of aldosterone in cardio-renal-metabolic diseases.We are focused on improving outcomes for people managing hypertension, CKD and related diseases that are driven by dysregulated aldosterone. About Aldosterone
Show all investments...

NovaCapital
VC Fund · Milano, Lombardia, Italy · 1 investments in Austria Biotech startups

NovaCapital invests in the union between entrepreneurs and innovation. It offers international and managerial experience, to transform innovative start-ups and already established companies into structured companies, with managerial skills and an international network.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Italy, Austria

Investor stats

  • Total investments: 12
  • Lead/follow: no public data

Portfolio highlights

  • EarlySight — EarlySight start-up company is founded in order to accelerate the development and to bring the technology to clinics.
  • BeDimensional — New Material Solution
  • Magentiq Eye Ltd — AI assisted colonoscopy by MAGENTIQ EYE set a new standard of , recognized by the gastroenterology community for its superior performance.
Show all investments...

Pace Ventures
VC Fund · Berlin, Berlin, Germany · 1 investments in Austria Biotech startups

Investing at the intersection of climate and health.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Information Technology
  • Stage:Seed, Pre-Seed
  • Geography: United States, Germany, Austria

Investor stats

  • Total investments: 13
  • Lead/follow: no public data

Portfolio highlights

  • Cellbyte — AI Agents for Pricing and Market Access Teams in the Pharmaceutical Industry.
  • Vema Hydrogen — Vema Hydrogen is a pioneering clean hydrogen production company. It helps to fight the enormous decarbonization issue.
  • ChemFinity Technologies — ChemFinity Technologies is a chemical company that offers critical metal recovery, water purification, and gas separation services.
Show all investments...

Borregaard ASA
VC Fund · Sarpsborg, Ostfold, Norway · 1 investments in Austria Biotech startups

Borregaard operates one of the world's most advanced and sustainable biorefineries.

Show more...

Investment focus

  • Industry: Biotechnology, Chemical Engineering
  • Stage:Seed
  • Geography: Austria

Investor stats

  • Total investments: 3
  • Lead/follow: no public data

Portfolio highlights

  • Kaffe Bueno — Kaffe Bueno upcycles coffee waste into active and functional ingredients for cosmetics, nutraceuticals and functional foods.
  • Alginor ASA — Alginor ASA is a marine biotech company committed to total utilisation of kelp through novel methods, making more than just alginates.
  • Lignovations — Lignovations develops high-performance ingredients from biomass. Accelerating the transition to a sustainable society.
Show all investments...

Satgana
VC Fund · Luxembourg, Luxembourg, Luxembourg · 1 investments in Austria Biotech startups

Satgana is a global Climate Tech Venture Capital firm backing purpose-driven founders building a planet-positive future, in Europe and Africa.

Show more...

Investment focus

  • Industry: Electronics, B2B, Biotechnology
  • Stage:Pre-Seed, Seed
  • Geography: Kenya, France, Austria

Investor stats

  • Total investments: 16
  • Lead/follow: no public data

Portfolio highlights

  • Voltiris — Unlock renewable energy in your greenhouse with Voltiris' spectral filtering technology.
  • NitroVolt — NitroVolt: the next generational step of sustainable ammonia.
  • Brineworks — Industry leading costs through cutting edge electrochemistry, and renewably powered intermittent operation
Show all investments...

RKP InnoInvest
VC Fund · Hartberg, Steiermark, Austria · 1 investments in Austria Biotech startups

RKP InnoInvest provides Investment capital and strategic services support progressive and dynamic start-ups and companies.

Show more...

Investment focus

  • Industry: Biotechnology, Food and Beverage
  • Stage:Seed
  • Geography: Austria

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • Hakuma — Hakuma is the full load of Matcha to which mango, lemon, ginger, agave and Baobab join.
  • Econutri — Recycling CO2 for sustainable protein production
Show all investments...

Tet Ventures
VC Fund · Berlin, Berlin, Germany · 1 investments in Austria Biotech startups

Tet Ventures is one of the most active global food-tech investors. We work with and invest in technology that can improve the food system.

Show more...

Investment focus

  • Industry: Food and Beverage, Biotechnology, E-Commerce
  • Stage:Seed, Pre-Seed
  • Geography: United States, Germany, United Kingdom

Investor stats

  • Total investments: 38
  • Lead/follow: no public data

Portfolio highlights

  • Afterlife Ag — Eliminate organic waste from going into landfills. Peat upcycles your food waste into fresh, sustainable, and delicious mushrooms.
  • FORAY bioscience — FORAY bioscience is a biotechnology company that uses biomanufacturing techniques to produce wood products.
  • Prolific Machines — Difficult protein production made simple. A next-generation expression system for next-generation therapeutics.
Show all investments...

HackCapital
VC Fund · Lausanne, Vaud, Switzerland · 1 investments in Austria Biotech startups

Join FoodTech focused investors looking to back impact-driven founders shaping our food system

Show more...

Investment focus

  • Industry: Biotechnology, Food and Beverage, Food Processing
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, Israel, United Kingdom

Investor stats

  • Total investments: 28
  • Lead/follow: no public data

Portfolio highlights

  • twig bio — twig bio operates as a bioengineering startup. twig bio using AI and robotics to find sustainable replacements for harmful ingredients.
  • Cultivated Biosciences — Cultivated - Creamy, dairy-free indulgence
  • UNCAGED Innovations — What if we could make leather without the animal? We are a biomaterials company combining the power of nature and technology to reimagine leather.
Show all investments...

Biotech Investor funding in Austria at a glance

Stats across 190 deals from 211 investors.

211
investors
in Austria Biotech startups
190
deals
in Austria Biotech startups
$2.7M
median round
in Austria Biotech startups
47%
lead investors
lead at least one round
27%
Seed
most common funding stage
94/6
VC / Angel
share of investor count

Access all 211 investors in Austria Biotech startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotech Investors in Austria investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 211 investors investing in Austria Biotech startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists